科笛-B(02487)：CU-40104(外用度他雄胺药剂)新药临床试验申请获得国家药监局临床试验默示许可

智通财经03-16

智通财经APP讯，科笛-B(02487)发布公告，本集团的CU-40104(外用度他雄胺药剂)的新药临床试验(IND)申请已获得中华人民共和国国家药品监督管理局(国家药监局)临床试验默示许可，适应症为治疗雄激素性脱发。CU-40104是一种由本集团自主开发的外用度他雄胺。度他雄胺作为特异性I型及II 型5α-还原酶竞争抑制剂抑制头皮中睾酮转化为双氢睾酮，可治疗雄激素性脱发。本集团正在研发的外用配方...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2619484884?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-16 08:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2619484884","market":"hk","top_or_hot":-1,"title":"科笛-B(02487)：CU-40104(外用度他雄胺药剂)新药临床试验申请获得国家药监局临床试验默示许可","media":"智通财经","content":"<div>\n<p>智通财经APP讯，科笛-B(02487)发布公告，本集团的CU-40104(外用度他雄胺药剂)的新药临床试验(IND)申请已获得中华人民共和国国家药品监督管理局(国家药监局)临床试验默示许可，适应症为治疗雄激素性脱发。CU-40104是一种由本集团自主开发的外用度他雄胺。度他雄胺作为特异性I型及II 型5α-还原酶竞争抑制剂抑制头皮中睾酮转化为双氢睾酮，可治疗雄激素性脱发。本集团正在研发的外用配方...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1414072.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>科笛-B(02487)：CU-40104(外用度他雄胺药剂)新药临床试验申请获得国家药监局临床试验默示许可</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n科笛-B(02487)：CU-40104(外用度他雄胺药剂)新药临床试验申请获得国家药监局临床试验默示许可\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-16 08:29 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1414072.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，科笛-B(02487)发布公告，本集团的CU-40104(外用度他雄胺药剂)的新药临床试验(IND)申请已获得中华人民共和国国家药品监督管理局(国家药监局)临床试验默示许可，适应症为治疗雄激素性脱发。CU-40104是一种由本集团自主开发的外用度他雄胺。度他雄胺作为特异性I型及II 型5α-还原酶竞争抑制剂抑制头皮中睾酮转化为双氢睾酮，可治疗雄激素性脱发。本集团正在研发的外用配方...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1414072.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02487","symbol_name":"科笛-B","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1414072.html","article_id":"2619484884","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2619484884","pubTimestamp":1773620964,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，科笛-B 发布公告，本集团的CU-40104的新药临床试验申请已获得中华人民共和国国家药品监督管理局临床试验默示许可，适应症为治疗雄激素性脱发。本集团正在研发的外用配方可使度他雄胺直接应用于头皮的作用部位，相比口服度他雄胺，预期外用配方可减少全身性暴露及副作用。本集团相信，CU-40104将进一步丰富本集团的毛发疾病产品矩阵，为本集团已获得国家药监局上市批准的CU-40102起到有价值的补充及协同作用。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"02487":"科笛-B","BK1161":"生物科技"},"translate_title":"Codi-B (02487): CU-40104 (topical dutasteride drug) new drug clinical trial application obtained implied clinical trial license from the State Food and Drug Administration","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02487":1.5},"content_text":"智通财经APP讯，科笛-B(02487)发布公告，本集团的CU-40104(外用度他雄胺药剂)的新药临床试验(IND)申请已获得中华人民共和国国家药品监督管理局(国家药监局)临床试验默示许可，适应症为治疗雄激素性脱发。CU-40104是一种由本集团自主开发的外用度他雄胺。度他雄胺作为特异性I型及II 型5α-还原酶竞争抑制剂抑制头皮中睾酮转化为双氢睾酮，可治疗雄激素性脱发。本集团正在研发的外用配方可使度他雄胺直接应用于头皮的作用部位，相比口服度他雄胺(已在全球多个国家获批用于治疗雄激素性脱发)，预期外用配方可减少全身性暴露及副作用。本集团相信，CU-40104将进一步丰富本集团的毛发疾病产品矩阵，为本集团已获得国家药监局上市批准的CU-40102(外用非那雄胺喷雾剂)起到有价值的补充及协同作用。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2619484884","isCrawlerRequest":true}